Yeshwant S. Bakhle (born 1936), is a British pharmacologist.
Yeshwant S. Bakhle | |
|---|---|
| Born | 1936 (age 87–88) |
| Nationality | British |
| Occupation | Pharmacologist |
| Employer | Imperial College London |
Bakhle studied chemistry, with supplementary chemical pharmacology, in the Department of Pharmacology at the University of Oxford, later obtaining both a DPhil and, in 1993, a DSc there.[1]
He spent two years at Yale University as a Fulbright Fellow, then in 1965 obtained a position at the Royal College of Surgeons' Department of Pharmacology under John Vane.[1][2] He was appointed reader in biochemical pharmacology there in 1980.[1]
Later in his career, he moved to the National Heart and Lung Institute at Imperial College London, as a senior research fellow, a position which became honorary upon his retirement.[1][3]
He served as a senior editor at the British Journal of Pharmacology from 2001 to 2006, and was subsequently press editor there.[1]
He became an Honorary Fellow of the British Pharmacological Society in 2002.[2]
References
edit- ^ a b c d e Caroline Overy; Tilli Tansey, eds. (2013). Drugs Affecting 5-HT Systems. Wellcome Witnesses to Contemporary Medicine. History of Modern Biomedicine Research Group. ISBN 978-0-902238-87-9. Wikidata Q29581800.
- ^ a b "Dr Y.S. (Mick) Bakhle MA DPhil DSc". British Pharmacological Society - Honorary Fellows Directory. Retrieved 21 July 2021.
- ^ "A-Z our people". Imperial College London. Retrieved 3 August 2017.
External links
edit- Y S Bakhle on the History of Modern Biomedicine Research Group website
- Y S Bakhle at IMDb
 | This article about a British scientist is a stub. You can help Wikipedia by expanding it. |